Inspirion Delivery Sciences LLC:
MorphaBond ER™ US commercial launch Nov 2017 (FDA-approved, first single-entity abuse deterrent ER morphine product) and RoxyBond™ (FDA approved, first and only IR abuse-deterrent opioid product) both licensed to Daiichi Sankyo, Inc. Novel extended and immediate release technologies enable pain medications with abuse deterrent features, addressing the Opioid epidemic.
Biotechnology, Specialty Pharmaceutical
100 Southgate Parkway
Morristown, NJ 07960
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.